Essais liés3clinical trials
VilleNîmeslocalisation
PaysFrancelocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT05819359

Ouvrir le site du centre

Essais cliniques associés

3
MoléculeIndication / populationPhaseNCTTitreStatut
BIA 28-6156 10 mg Parkinson Phase 2 NCT05819359 ACTIVATE — Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD COMPLETED
BIOMOG — Immunologic Biomarker Profile of Cerebrospinal Fluid SEP À vérifier NCT04202055 BIOMOG — Immunologic Biomarker Profile of Cerebrospinal Fluid COMPLETED
ACU-BRAIN — Brain Connectome for Acupuncture-treated Migraine Patients Migraine Non applicable NCT04157192 ACU-BRAIN — Brain Connectome for Acupuncture-treated Migraine Patients COMPLETED